NGC – National Guideline Clearinghouse – USA (purtroppo non esiste più)

AACE – American Association Clinical Endocrinologists

SIGN – Scottish Intercollegiate Guidelines Network – Scotland

CANADIAN MEDICAL ASSOCIATION – Clinical Practice Guidelines – Canada

NICE – National Institute of Clinical Excellence – UK

NIH – The National Institutes of Health – USA

PRODIGY Guidance – NHS Dept of Health – UK

AGREE - Appraisal of Guidelines Research and Evaluation

Gattrell WT, et al.
ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi.
PLoS Med 2024, 21: e1004326 (free full text).

El-Hajj Fuleihan G, Clines GA, Hu MI, et al.
Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2023, dgac621 (free full text).

Giustina A, Bouillon R, Dawson-Hughes B, et al.
Vitamin D in the older population: a consensus statement.
Endocrine 2023, 79: 31–44 (free full text).

Società Italiana Talassemie ed Emoglobinopatie.
Le principali complicanze endocrinologiche nelle Emoglobinopatie. Buone Pratiche SITE.
Recenti Progressi in Medicina 2022, 113: 495-554 (free full text).

DeTora LM, Toroser D, Sykes A, et al.
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Ann Intern Med 2022, 175: 1298-304.

Cusi K, et al.
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Co-sponsored by the American Association for the Study of Liver Diseases (AASLD).
Endocr Pract 2022, 28: 528-62. (free full text)

US Preventive Services Task Force.
Statin use for the primary prevention of cardiovascular disease in adults.
JAMA 2022, 328: 746-53 (free full text).

Husebye ES, et al.
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline.
Eur J Endocrinol 2022, 187: G1–21 (free full text).

FitzGerald JD, et al.
2020 American College of Rheumatology guideline for the management of gout.
Arthritis Care Res 2020, 72: 744–60. (free full text)

Couturier J, et al.
Canadian practice guidelines for the treatment of children and adolescents with eating disorders.
J Eating Dis 2020, 8: 4 (free full text).

Bennett BL, et al
Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-Associated Hyponatremia: 2019 Update.
Wildern Envirom Med 2020, 31: 50-62 (free full text).

Hiroshi A, et al.
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.
Endocr J 2019, 66: 581-6 (free full text).

Van Spronsen FJ, van Wegberg AMJ, Ahring K, et al.
Key European guidelines for the diagnosis and management of patients with phenylketonuria.
Lancet Diabetes Endocrinol 2017, 5: 743-56 (free full text).

Roman CJ, Cifu AS, Stein SL.
Management of Acne Vulgaris.
JAMA 2016, 316: 1402-3.

Qaseem A, McLean RM, Starkey M, Forciea MA.
Diagnosis of acute gout: a clinical practice guideline from the American College of Physicians.
Ann Intern Med 2106, doi:10.7326/M16-0569 (free full text).

Qaseem A, Harris RP, Forciea MA.
Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians.
Ann Intern Med 2016, doi:10.7326/M16-0570 (free full text).

Toplak H, Stauber R, Sourij H.
European Association for the Study of the Liver (EASL) & European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO).
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
Diabetologia 2016, 59: 1121–40 (free full text).

European Medicines Agency.
Guide to information on human medicines evaluated by EMA. What the Agency publishes and when.
10 May 2016 EMA/515416/2015 (free full text).

Spasovski G, Vanholder R, Allolio B, et al
Clinical practice guideline on diagnosis and treatment of hyponatraemia.
Eur J Endocrinol 2014, 170: G1–47 (free full text).

NODULO - CARCINOMA - IPER/IPO - ORBITOPATIA - VARIE - TEST FUNZIONALI

Nodulo

Orloff LA, Noel JE, Stack BC Jr, Russell MD, Angelos P, Baek JH, et al.
Radiofrequency Ablation and Related Ultrasound-Guided Ablation Technologies for Treatment of Benign and Malignant Thyroid Disease: An International Multidisciplinary Consensus Statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association.
Head Neck 2022, 44: 633-60.

Papini E, Monpeyssen H, Frasoldati A, Hegedüs L.
2020 European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules.
Eur Thyroid J 2020, DOI: 10.1159/000508484 (free full text).

Zhou JQ, et al.
2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.
Endocrine 2020, 70: 256-79 (free full text).

Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, Fugazzola L, Guglielmi R, Lombardi CP, Miccoli P, Papini E, Pellegriti G, Pezzullo L, Pontecorvi A, Salvatori M, Seregni E, Vitti P.
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.
J Endocrinol Invest 2018, 41: 849–76 (free full text)

Russ G, Bonnema SJ, Erdogan MF, et al.
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS.
Eur Thyroid J 2017, 6: 225–37 (free full text).

Paschke R, et al.
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics.
Eur Thyroid J 2017, 6: 115–29 (free full text).

Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, Paschke R, Valcavi R, Vitti P, on behalf of the AACE/ACE/AME Task Force on Thyroid Nodules.
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules – 2016 update.
Endocr Pract 2016, 22 (suppl 1):  2-60 (free full text).

The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.
Thyroid 2015, DOI: 10.1089/thy.2015.0020.

Huang TW, et al.
Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer.
BMC Medicine 2013, 11: 191 (free full text).

Papini E, Negro R, Pinchera A, Guglielmi R, Baroli A, Beck-Peccoz P, Garofalo P, Pisoni MP, Zini M, Elisei R and Chiovato L.
Thyroid Nodule and Differentiated Thyroid Cancer Management in Pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.
J Endocrinol Invest 2010, 33: 579-86.

Carcinoma

Shindo ML, et al.
Management of invasive well-differentiated thyroid cancer. An American Head and Neck society consensus statement.
Head Neck 2014, DOI: 10.1002/hed.23619.

British Thyroid Association.
Guidelines for the management of thyroid cancer. 3rd Edition.
Clin Endocrinol 2014, 81 suppl 1: 1-122 (free full text).

Dralle H, Musholt TJ, Schabram J, et al.
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.
Langenbeck Arch Surg 2013, 398: 347-75.

Leenhardt L, et al.
2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.
Eur Thyroid J 2013, 2: 147–59 (free full text).

Huang TW, et al.
Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer.
BMC Medicine 2013, 11: 191 (free full text).

Iper-ipotiroidismo

van Trotsenburg P, et al.
Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update— An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.
Thyroid 2021, 31: 387-419 (free full text).

Bednarczuk T, et al.
2021 European Thyroid Association Guidelines for the management of iodine-based contrast media-induced thyroid dysfunction.
Eur Thyroid J 2021, 10: 269–84 (free full text).

Bekkering GE, et al.
Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline.
BMJ 2019, 365: l2006 (free full text).

Persani L, Brabant G, Dattani M, et al.
2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism.
Eur Thyroid J 2018, 7: 225-37 (free full text).

Bartalena L, et al.
2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction.
Eur Thyroid J 2018, 7: 55–66 (free full text).

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA.
2016 American Thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.
Thyroid 2016, 26:1343-421 (free full text).

Satoh T, et al.
2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society.
Endocr J 2016, 63, 1025-64 (free full text).

Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ.
The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism
Eur Thyroid J 2015, 4: 149-63 (free full text).

Jonklaas J, et al; American Thyroid Association Task Force on Thyroid Hormone Replacement.
Guidelines for the treatment of hypothyroidism.
Thyroid 2014, 24: 1670-751 (free full text).

Lazarus J, et al.
2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.
Eur Thyroid J 2014, 3: 76–94 (free full text).

Léger J, et al.
European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.
J Clin Endocrinol Metab 2014, 99: 363–84.

Pearce SHS, et al.
2013 ETA guideline: management of subclinical hypothyroidism.
Eur Thyroid J 2013, 2: 15–28 (free full text).

Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA.
Clinical Practice Guidelines for Hypothyroidism in Adults: Co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.
Endocr Pract 2012, 11: 1-207.

Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN.
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Endocrine Practice 2011, 17: 456-520 (free full text).

Orbitopatia

Burch HB, Perros P, Bednarczuk T, et al.
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Eur Thyroid J 2022, 11: e220189 (free full text) e Thyroid 2022, 32: 1439-70 (free fulll text).

Bartalena L, et al.
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guideline for the medical management of Graves’ orbitopathy.
Eur J Endocrinol 2021, 185: G43-67 (free full text).

Bartalena L, Baldeschi L, Boboridis K, et al; on behalf ofEuropean Group on Graves' Orbitopathy (EUGOGO).
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the management of Graves' orbitopathy.
Eur Thyroid J 2016, 5: 9-26. (free full text)

Varie

Poppe K, et al.
2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.
Eur Thyroid J 2020, 9: 281-95 (free full text)

Patel KN, et al.
Executive summary of the American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults.
Ann Surg 2020, 271: 399-410.

Muller I, et al.
2019 European Thyroid Association guidelines on the management of thyroid dysfunction following immune reconstitution therapy
Eur Thyroid J 2019, 8: 173–85 (free full text).

WHO.
Iodine thyroid blocking. Guidelines for use in planning for and responding to radiological and nuclear emergencies.
2017. (free full text)

Alexander EK, Pearce NE, Brent GA, et al.
2016 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.
Thyroid 2017, 27: 315-89 (free full text).

LeFevre ML, on behalf of the U.S. Preventive Services Task Force.
Screening for thyroid dysfunction: U.S. Preventive Services Task Force Recommendation Statement.
Ann Int Med 2015, 162: 641-50.

Chen AY, et al.
American Thyroid Association statement on optimal surgical management of goiter.
Thyroid 2014, 24: 181-9 (free full text).

Beck-Peccoz P, et al.
2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.
Eur Thyroid J 2013, 2: 76-82 (free full text).

Test funzionali

Association for Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation
UK Guidelines for the Use of Thyroid Function Tests.
2006 Full text

Taïeb D, et al.
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert consensus statement.
Nature Rev Endocrinol 2024, 20: 168–84 (free full text).

Fassnacht M, Tsagarakis S, Terzolo M, et al.
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Eur J Endocrinol 2023, 189: G1–42 (free full text).

Taieb D, et al.
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Lancet Diabetes Endocrinol 2023, 11: 345–61.

Tabarin A, Assié G, Barat P, et al.
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing’s syndrome.
Annal Endocrinol 2022, 83: 119-41.

Fleseriu M, et al.
Consensus on diagnosis and management of Cushing’s disease: a guideline update.
Lancet Diabetes Endocrinol 2021, 9: 847-75 (free full text).

Rossi GP, et al.
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.
Int J Cardiol Hypertens 2020, 5: 100029 (free full text).

Lorenz K, Langer P, Niederle B, et al.
Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).
Langenbecks Arch Surg 2019, 404: 385-401.

Fassnacht M, et al.
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Eur J Endocrinol 2018, 179: G1-46 (free full text).

Phyllis W. Speiser PW, et al.
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2018, doi.org/10.1210/jc.2018-01865 (free full text).

Carey, RM et al.
Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline.
Ann Intern Med 2018, doi:10.7326/M17-3203 (free full text).

Qaseem A, Wilt TJ, Rich R, et al, for the Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians.
Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
Ann Intern Med 2017, 166: 430-7 (free full text).

Plouin PF, Amar L, Dekkers OM, et al.
European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.
Eur J Endocrinol 2016, 174: G1–10 (free full text).

Stigliano A, Chiodini I, Giordano R, et al.
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).
J Endocrinol Invest 2016, 39: 103-21.

Funder JF, Carey RM, Mantero F, et al.
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Med 2016, DOI:org/10.1210/jc.2015-4061.

Bornstein SR, Allolio B, Arlt W, et al.
Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Med 2016, 101: 364-89 (free full text).

Lenders JWM, et al.
Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2014, 99: 1915-42.

Husebye ES, Allolio B, Arlt W, et al.
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.
J Intern Med 2014, 275: 104-15 (free full text).

James PA, et al.
2014 Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
JAMA doi:10.1001/jama.2013.284427 (free full text).

Khan AA, Bilezikian JP, Brandi ML, et al.
Evaluation and management of hypoparathyroidism: summary statement and guidelines from the second international workshop.
J Bone Min Res 2022, 37: 2568–85 (free full text).

Bilezikian JP, et al.
Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop.
J Bone Min Res 2022, 37: 2293–314. (free full text).

Ovčariček P, e al.
The EANM practice guidelines for parathyroid imaging.
Eur J Nucl Med Molec Imaging 2021, 48: 2801–22 (free full text).

Orloff LA, Wiseman SM, Bernet VJ, et al, for the American Thyroid Association Surgical Affairs Committee Writing Task Force.
American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults.
Thyroid 2018, 28: 830-41.

Wilhelm SM, et al.
The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism.
JAMA 2016, 151: 959-68.

Brandi ML, et al.
Management of hypoparathyroidism: summary statement and guidelines.
J Clin Endocrinol Metab 2016, 101: 2273-83.

Bollerslev J, et al.
European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults.
Eur J Endocrinol 2015, 173: G1–G20 (free full text).

Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S.
Italian Society of Endocrinology consensus statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
J Endocrinol Invest 2015, 38: 577-93.

Bilezikian JP, et al.
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop.
J Clin Endocrinol Metab 2014, doi: 10.1210/jc.2014-1413 (free full text).

Silverberg SJ, et al.
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop.
J Clin Endocrinol Metab 2014, doi: 10.1210/jc.2014-1415 (free full text).

Eastell R, et al.
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop.
J Clin Endocrinol Metab 2014, doi: 10.1210/jc.2014-1414 (free full text).

Udelsman R, et al.
The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop.
J Clin Endocrinol Metab 2014, doi: 10.1210/jc.2014-2000 (free full text).

Marcocci C, et al.
Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop.
J Clin Endocrinol Metab 2014, doi: 10.1210/jc.2014-1417 (free full text).

Rosato L, et al.
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).
J Endocrinol Invest 2014, 37: 149–65.

Tanaka Y, et al.
The 2023 guidelines for the management and treatment of glucocorticoid‑induced osteoporosis.
J Bone Min Metab 2024, 42: 143–54 (free full text).

Corrao G, et al.
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021.
Front Endocrinol 2023, 14: 1137671 (free full text).

Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, et al.
Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians.
Ann Intern Med 2023, DOI: 10.7326/M22-1034.

Camacho PL, et al.
American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2020 update.
Endocr Pract 2020, 26 (suppl 1): 1-46 (free full text).

Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D.
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2019, 104: 1595-622 (free full text).

Ralston SH, et al.
Diagnosis and management of Paget’s disease of bone in adults: a clinical guideline.
J Bone Min Res 2019: e3657 (free full text).

Kanis JA, et al.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Osteopor Int 2019, 30: 3-44.

Pludowski P, et al.
Vitamin D supplementation guidelines.
J Steroid Biochem Mol Biol 2018, 175: 125-35.

Dell R, Greene D.
A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
Osteoporosis Int 2018: 29: 1277-83.

Buckley L, Guyatt G, Fink HA, et al.
2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis.
Arthritis Rheumatol 2017, 69: 1521-37.

Ketteler M, et al.
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters.
Kidney International 2017, 92: 26–36 (free full text).

SIGG, SIOT, SIMI, SIR, SIOMMMS, SIMFER, SIE, SIMG.
Linee Guida sulla gestione dell’Osteoporosi e delle Fratture da fragilità.
2017 (free full text).

Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB.
American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2016.
Endocr Pract 2016, 22 suppl 4: 1-42 (free full text).

Kopecky SL, BauerDC, Gulati M, Nieves JW, Singer AJ, Toth PP, Underberg JA, Wallace TC, Weaver CM.
Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease in generally healthy adults: a clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology.
Ann Intern Med 2016, 165: doi:10.7326/M16-1743 (free full text).

Munns CF, et al.
Global consensus recommendations on prevention and management of nutritional rickets.
J Clin Endocrinol Metab 2016, 101: 394-415 (free full text)..

Singer RF, et al.
Paget’s disease of bone: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2014, 99: 4408-22.

Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS.
Osteoporosis in men: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2012, 97: 1802–22.

Institute for Clinical Systems Improvement
Diagnosis and treatment of osteoporosis
2011.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM.
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96: 1911–30.

Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; for the Scientific Advisory Council of Osteoporosis Canada.
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.
CMAJ 2010, 182: 1864-73.

Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M, on behalf of the National Osteoporosis Guideline Group (NOGG).
Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
2009.

Goudet P, et al.
French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1.
Ann Endocrinol 2024, 85: 2-19 (free full text).

Kos-Kudła B, et al.
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.
J Neuroendocrinol 2023, 35: ce13343 (free full text).

Hofland J, et al.
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
J Neuroendocrinol 2023, 35: e13318 (free full text).

Panzuto F, et al.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3.
J Neuroendocrinol 2023, 35: e13306 (free full text).

Eads JR, et al.
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms.
Endocr Relat Cancer 2023, 30: e220206 (free full text).

Rinke A, et al.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.
J Neuroendocrinol 2023, 35: e13309 (free full text).

Sorbye H, et al.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.
J Neuroendocrinol 2023, 35: e13249 (free full text).

Grozinsky-Glasberg S, et al.
European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease.
J Neuroendocrinol 2022, 34: e13146 (free full text).

Dromaine C, et al.
ENETS consensus guidelines for synoptic reporting of radiology studies.
J Neuroendocrinol DOI: 10.1111/jne.13060 (free full text).

Gallo M, Adinolfi V, Morviducci L, et al.
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
ESMO Open 2021, 6: 100155 (free full text).

Silvestris N, Argentiero A, Natalicchio A, et al.
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
ESMO Open 2021, 6: 100153 (free full text).

Silvestris N, Argentiero A, Beretta G, et al.
Management of metabolic side effects from targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana di Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD), Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Crit Rev Oncol Hematol 2020, 154: 103066.

Castinetti F, Albarel F, Archambeaud F, et al.
French Endocrine Society Guidance on endocrine side effects of immunotherapy.
Endocr Relat Cancer 2019, 26: G1-18 (free full text).

Brahmer JR, Lacchetti C, Schneider BJ, et al; National Comprehensive Cancer Network.
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline.
J Clin Oncol 2018, 36: 1714-68 (free full text).

Higham CE, Olsson-Brown A, Carroll P, et al; Society for Endocrinology Clinical Committee.
Society For Endocrinology endocrine emergency guidance: acute management of the endocrine complications of checkpoint inhibitor therapy.
Endocr Connect 2018, 7: G1-7.

Sklar CA, Antal Z, Chemaitilly W, Cohen LE, Follin C, Meacham LR, Murad MH.
Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2018, 103: 2761–84 (free full text).

Haanen JBAG, Carbonnel F, Robert C, et al; ESMO Guidelines Committee.
Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.
Ann Oncol 2017, 28 (suppl 4): iv119-42 (free full text).

Puzanov I, Diab A, Abdallah K, et al; Society for Immunotherapy of Cancer Toxicity Management Working Group.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
J Immunother Cancer 2017, 5: 95 (free full text).

Perren A, Couvelard A, Scoazec JY, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification.
Neuroendocrinology 2017, 105: 196-200.

Oberg K, Couvelard A, Delle Fave G, et al.
ENETS Consensus Guidelines for standard of care in Neuroendocrine Tumours: Biochemical Markers.
Neuroendocrinology 2017, 105: 201-11.

Sundin A, Arnold R, Baudin E, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.
Neuroendocrinology 2017, 105: 212-44.

Partelli S, Bartsch DK, Capdevila J, et al.
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.
Neuroendocrinology 2017, 105: 255-65.

Pavel M, Valle J, Eriksson B, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy ‐ Biotherapy and Novel Targeted Agents.
Neuroendocrinology 2017, 105: 266-80.

Garcia-Carbonero R, Rinke A, Valle JW, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy.
Neuroendocrinology 2017, 105: 281-94.

Hicks RJ, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.
Neuroendocrinology 2017, 105: 295-309.

Falconi M, Eriksson B, Kaltsas G, et al, and all other Vienna Consensus Conference participants.
ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors.
Neuroendocrinology 2016, 103 (2): 153-171.

Niederle B, Pape UF, Costa F, et al, and all other Vienna Consensus Conference participants.
ENETS Consensus Guidelines update for neuroendocrine neoplasm of the jejunum and ileum.
Neuroendocrinology 2016, 103:125-138.

Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al, and all other Vienna Consensus Conference participants.
ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms.
Neuroendocrinology 2016, 103 (2): 119-124.

Pavel M, O'Toole D, Costa F, Capdevila J, et al, and all other Vienna Consensus Conference participants.
ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site.
Neuroendocrinology 2016, 103:172-185.

Associazione Italiana Oncologia Medica.
Linee guida Neoplasie Neuroendocrine (in condivisione con It.a.net.)
2016 (free full text).

AIOM - SIE – SIGO.
Raccomandazioni su oncofertilità (free full text).

AIOM.
Linee guida neoplasie dell’utero: endometrio e cervice.
2015 (free full text).

Pavel M, Grossman A, Arnold R, et al.
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.
Neuroendocrinology 2010, 91: 326–32. 

Kianmanesh R, Ruszniewski P, Rindi G, et al.
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors.
Neuroendocrinology 2010, 91: 333–40. 

Kos-Kudła B, O’Toole D, Falconi M, et al.
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.
Neuroendocrinology 2010, 91: 341–50.

Muscogiuri G, El Ghoch M, Colao A, et al. Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO).
European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis.
Obes Facts 2021, 14: 222-45 (free full text).

Oppert JM, et al.
Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group.
Obesity Rev 2021, 22 (S4): e13273 (free full text).

O’Kane M, et al.
British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery—2020 update.
Obesity Rev 2020, 21: e13087(free full text).

Wharton S, et al.
Obesity in adults: a clinical practice guideline.
CMAJ 2020, 192: E875-91 (free full text).

Pasquali R, et al.
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.
Eur J Endocrinol 2020, 182: G1–32 (free full text).

Simon A, et al.
Guidelines for the management of pregnant women with obesity: A systematic review.
Obesity Rev 2020, 21: e12972 (free full text).

Mechanick JI, et al.
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.
Endocr Pract 2019, DOI:10.4158/GL-2019-0406 (free full text).

Durrer Schutz D, et al.
European practical and patient-centred guidelines for adult obesity management in primary care.
Obes Facts 2019, 12: 40–66 (free full text).

Piercy KL, et al.
The physical activity guidelines for Americans.
JAMA 2018, 320: 2020-8 (free full text).

SIO-ADI
Standard Italiani per la cura dell'obesità.
2016-7 (free full text)

Styne DM, Arslanian SA, Connor EL, et al.
Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2017, 102: 709–57 (free full text).

Società Italiana di Chirurgia dell’Obesità e delle malattie metaboliche.
Linee guida di chirurgia dell’obesità.
Edizione 2016 (free full text).

Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother K, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T.
The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline.
J Clin Endocrinol Metab 2016, DOI: 10.1210/jc.2016-2466.

Garvey WT, Mechanick JI, ECNU, Brett EM, et al
American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for comprehensive medical care of patients with obesity – executive summary.
Endocr Pract 2016, DOI:10.4158/EP161365.GL (free full text).

Canadian Task Force on Preventive Health Care.
Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care.
CMAJ 2015, 187: 411-21 (free full text).

Apovian CM, et al.
Pharmacological management of obesity: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2015, doi: 10.1210/jc.2014-3415.

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society.
Circulation published online November 12, 2013. DOI: 10.1161/01.cir.0000437739.71477.ee (free full text).

Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C.
Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline
J Clin Endocrinol Metab 2010, 95: 4823–43.

Institute for Clinical Systems Improvement (ICSI)
Prevention and management of obesity (mature adolescents and adults)
2009.

Korbonits M, et al.
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 1, general recommendations.
Nature Rev Endocrinol 2024, 20: 278–89 (free full text).

Korbonits M, et al.
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 2, specific diseases.
Nature Rev Endocrinol 2024, 20: 290–309 (free full text).

Gan HW, et al.
National UK guidelines for the management of paediatric craniopharyngioma.
Lancet Diabetes Endocrinol 2023, 11: 694–706.

Fleseriu M, et al.
Consensus on diagnosis and management of Cushing’s disease: a guideline update.
Lancet Diabetes Endocrinol 2021, 9: 847-75 (free full text).

Luger A, et al.
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy.
Eur J Endocrinol 2021,185: G1-33 (free full text).

Fleseriu M, et al.
A Pituitary Society update to acromegaly management guidelines.
Pituitary 2021, 24: 1–13 (free full text).

Yuen KCJ, et al.
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. 2019 AACE growth hormone task force.
Endocr Pract 2019, 25: 1191-232 (free full text).

Baldeweg SE, Ball S, Brooke A, et al, on behalf of the Society for Endocrinology Clinical Committee.
Inpatient management of cranial diabetes insipidus. (free full text)
Endocr Connect 2018, 7: G8–G11.

Persani L, Brabant G, Dattani M, et al.
2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism.
Eur Thyroid J 2018, 7: 225-37 (free full text).

Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM; European Society of Endocrinology.
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.
Eur J Endocrinol 2018, 178: G1-G24. (free full text)

Fleseriu M, Hashim IA, Karavitaki N, et al.
Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2016, 101: 3888-921.

Gordon CM, Ackerman KE, Berga SL, et al.
Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2017, 102: 1413-39 (free full text).

Aghi MK, Chen CC, Fleseriu M, Newman SA, Lucas JW, Kuo JS, Barkhoudarian G, Farrell CJ, Sheehan J, Ziu M, Dunn IF.
Congress of Neurological Surgeons systematic review and evidence-based guidelines on the management of patients with nonfunctioning pituitary adenomas: executive summary.
Neurosurgery 2016, 79: 521–3 (free full text).

Chen CC, Carter BS, Wang R, Patel KS, Hess C, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Zada G, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline on preoperative imaging assessment of patients with suspected nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E524–6 (free full text).

Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM, Patil CG, Litvack Z, Aghi MK, Zada G.
Congress of Neurological Surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E527–9 (free full text).

Newman SA, Turbin RE, Bodach ME, Tumialan LM, Oyesiku NM, Litvack Z, Zada G, Patil CG, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guidelines on pretreatment ophthalmology evaluation in patients with suspected nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E530–2 (free full text).

Lucas JW, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Aghi MK, Zada G.
Congress of Neurological Surgeons systematic review and evidence-based guidelines on primary management of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E533–5 (free full text).

Kuo JS, Barkhoudarian G, Farrell CJ, Bodach ME, Tumialan LM, Oyesiku NM, Litvack Z, Zada G, Patil CG, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline on surgical techniques and technologies for the management of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E536–8 (free full text).

Sheehan J, Lee CC, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Zada G, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E539–40 (free full text).

Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM, Oyesiku NM, Patel KS, Wang R, Carter BS, Chen JY, Chen CC, Patil CG, Litvack Z, Zada G, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E541–3 (free full text).

Baroni MG, et al.
SID/SIE guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.
J Endocrinol Invest 2016, 39: 235-55.

Katznelson L, et al.
Acromegaly: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2014, 99: 3933-51.

Giustina A, et al.
Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline.
J Endocrinol Invest 2014, 37: 1017–30 (free full text).

Beck-Peccoz P, et al.
2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.
Eur Thyroid J 2013, 2: 76-82 (free full text).

Katznelson L, Atkinson JLD, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK.
AACE Acromegaly guidelines.
Endocr Pract 2011, 17 suppl 4: 1-44.

Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML.
Evaluation and treatment of adult Growth Hormone deficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96:1587–609.

Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML.
Pituitary incidentaloma: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96: 894–904.

Melmed S, Casanueva F, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH.
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96: 273–88.

Handelsman Y, et al.
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm – 2020 executive summary.
Endocr Pract 2020, 26: 1196-1224 (free full text).

Newman CB, et al.
Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline
J Clin Endocrinol Metab 2020, 105: dgaa674 (free full text).

Rosenzweig JL, et al.
Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2019, 104: 3939–85 (free full text).

Arnett DK, et al.
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease.
J Am Coll Cardiol 2019, DOI: 10.1016/j.jacc.2019.03.010.

Jellinger PS, Handelsman Y, Rosenblit PD, et al.
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis.
Endocr Pract 2017, DOI:10.4158/EP171764.GL (free full text).

The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS).
2016 ESC/EAS guidelines for the management of dyslipidaemias.
Eur Heart J 2016, doi:10.1093/eurheartj/ehw272 (free full text).

Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members, Grundy SM, et al.
An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia—Full report.
J Clin Lipidol 2014, 8: 29-60.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation published online November 12, 2013. DOI: 10.1161/01.cir.0000437738.63853.7a (free full text).

Eckel RH, Jakicic JM, et al.
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation published online November 12, 2013. DOI: 10.1161/01.cir.0000437740.48606.d1 (free full text).

Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AFH.
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2012, 97: 2969–89.

Alteri A, et al.
ESHRE guideline: number of embryos to transfer during IVF/ICSI.
Human Reprod 2024, 39: 647–57 (free full text).

Teede HJ, et al.
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
J Clin Endocrinol Metab 2023, 108: 2447-69. Hum Reprod 2023, 38: 1655–79. Eur J Endocrinol 2023, 189: G43-64. (free full text)

The Guideline Group on Unexplained Infertility.
Evidence-based guideline: unexplained infertility.
Hum Reprod 2023, 38: 1881–90 (free full text).

World Professional Association for Transgender Health.
Standards of care for the health of transsexual, transgender, and gender nonconforming people. 8th Version
Int J Transgender Health 2022, 23 suppl 1: S1-S259. (free full text)

US Preventive Services Task Force.
Hormone therapy for the primary prevention of chronic conditions in postmenopausal persons.
JAMA 2022, 328: 1740-6 (free full text).

WHO.
WHO recommendations on maternal and newborn care for a positive postnatal experience.
2022. (free full text)

Practice Committee of the American Society for Reproductive Medicine.
Evidence-based treatments for couples with unexplained infertility: a guideline.
Fertil Steril 2020, 113: 305-22.

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, on behalf of the International PCOS Network.
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Simultaneously published (free full text) in Hum Reprod (2018, 33: 1602-18), Clin Endocrinol (2018, 89: 251-68), Fertil Steril (2018, 110: 364-79)

Practice Committee of the American Society for Reproductive Medicine.
The role of immunotherapy in in vitro fertilization: a guideline.
Fertil Steril 2018, 110: 387-400.

Martin KA, et al.
Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2018, doi: 10.1210/jc.2018-00241 (free full text).

Practice Committee of the American Society for Reproductive Medicine
Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline.
Fertil Steril 2017, 108: 426-41.

Practice Committee of the American Society for Reproductive Medicine.
Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline.
Fertil Steril 2017, 108: 416-25.

Gravholt CH, Andersen NH, Conway GS, et al.
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.
Eur J Endocrinol 2017, 177: G1-70 (free full text).

Gordon CM, Ackerman KE, Berga SL, et al.
Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2017, doi: 10.1210/jc.2017-00131 (free full text).

Practice Committee of the American Society for Reproductive Medicine.
Performing the embryo transfer: a guideline.
Fertil Steril 2017, 107: 882–96

Hembree WC, Cohen-Kettenis PT, Gooren L, et al.
Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2017, 102: 3869-903 (free full text).

The ESHRE Guideline Group on POI.
ESHRE Guideline: management of women with premature ovarian insufficiency.
Hum Reprod 2016, 31: 926-37 (free full text).

Lumsden MA, Davies M, Sarri G, et al,
Diagnosis and management of menopause. The National Institute of Health and Care Excellence (NICE) Guideline.
JAMA Internal Medicine 2016, doi: 10.1001/jamainternmed.2016.2761.

Asai Y, et al.
Management of acne: Canadian clinical practice guideline.
CMAJ 2016, 188: 118 (free full text).

European Society of Human Reproduction and Embryology.
Revised guidelines for good practice in IVF laboratories (2015) (free full text).

Stuenkel CA, Davis SR, Gompel A, et al.
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2015, doi.org/10.1210/jc.2015-2236.

Mintziori G, et al.
EMAS position statement: non-hormonal management of menopausal vasomotor symptoms.
Maturitas 2015, doi:10.1016/j.maturitas.2015.04.009.

Wierman ME, et al.
Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2014, 99: 3489-510.

Legro RS, Arslanian SA, Ehrmann DA, et al.
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
J Clin Endocrin Metab first published ahead of print October 22, 2013 as doi:10.1210/jc.2013-2350.

Qaseem A, et al.
Newer pharmacologic treatments in adults with type 2 diabetes: a clinical guideline from the American College of Physicians.
Ann Intern Med 2024, DOI: 10.7326/M23-2788 (free full text).

Samson S, et al.
American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update.
Endocr Pract 2023, 29: 305-40 (free full text).

Mustafa OG, et al, on behalf of the Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Management of Hyperosmolar Hyperglycaemic State (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Diabetic Med 2023, 40: e15005 (free full text).

McCall AL, et al.
Management of Individuals with diabetes at high risk for hypoglycemia: An Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2023, 108: 529–62 (free full text).

The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD).
Evidence-based European recommendations for the dietary management of diabetes.
Diabetologia 2023, 66: 965–85 (free full text).

Blonde L, et al.
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update.
Endocr Pract 2022, doi.org/10.1016/j.eprac.2022.08.002 (free full text)

Korytkowski MT, et al.
Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2022, 107, 2101–28 (free full text).

US Preventive Services Task Force.
Screening for prediabetes and type 2 diabetes in children and adolescents.
JAMA 2022, 328: 963-7 (free full text).

Dashora U, et al.
Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes –an updated guideline from the Joint British Diabetes Society for Inpatient Care.
Diabet Med 2022, 39: e14744.

Karalliedde J, et al.
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
Diabet Med 2022, 39: e14769.

Hassanein M, et al.
Diabetes and Ramadan: practical guidelines 2021.
Diabetes Res Clin Pract 2022, 185: 109185 (free full text).

The Joint British Diabetes Societies for Inpatient Care.
The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care.
Diabet Med 2022, 39: e14788. (free full text)

Mannucci E, et al.
Italian guidelines for the treatment of type 2 diabetes.
Acta Diabetologica 2022, 59: 579–622. (free full text)

Joharatnam-Hogan N, et al.
A guideline for the outpatient management of glycaemic control in people with cancer.
Diabet Med 2022, 39: e14636 (free full text).

Grunberger G, et al.
American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus.
Endocr Pract 2021, 27: 505-37 (free full text).

Chowdhury Da, et al.
Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation.
Diabet Medic 2021, 38:e14523.

Gallo M, Adinolfi V, Morviducci L, et al.
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
ESMO Open 2021, 6: 100155 (free full text).

Silvestris N, Argentiero A, Beretta G, et al.
Management of metabolic side effects from targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana di Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD), Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Crit Rev Oncol Hematol 2020, 154: 103066 (free full text).

Sinclair AJ, et al.
Joint British Diabetes Societies for Inpatient Care (JBDSIP) clinical guideline. Inpatient care of the frail older adult with diabetes: an Executive Summary.
Diabet Med 2020, 37: 1981–91 (free full text).

Garber AJ, et al.
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2020 executive summary.
Endocr Pract 2020, 26: 107-39.

Dhatariya K, et al.
Diabetes UK Position Statements Diabetes at the front door. A guideline for dealing with glucose related emergencies at the time of acute hospital admission from the Joint British Diabetes Society (JBDS) for Inpatient Care Group*.
Diabet Med 2020, 37: 1578-89.

The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA* guidelines on the management of blood cholesterol in diabetes.
Diabetes Care 2020, 43: 1673-8.

Hanif W, et al.
The South Asian Health Foundation (UK) Guidelines for Managing Diabetes during Ramadan.
Diabetes Res Clin Prac DOI: org/10.1016/j.diabres.2020.108145.

Sinclair AJ, et al , on behalf of an International Group of Experts.
Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an executive summary.
Diabet Med 2020, 37: 57-70.

Van Baak KD, et al.
Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management.
Wilderness Environm Med 2019, 30 (suppl 4): S121-40 (free full text).

LeRoith D, et al.
Treatment of diabetes in older adults: An Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2019, 104: 1520–74 (free full text).

Battelino T, et al.
Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range.
Diabetes Care 2019, DOI: 10.2337/dci19-0028 (free full text).

Davies MJ, et al.
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Diabetologia 2018, doi.org/10.1007/s00125-018-4729-5.

AMD-SID.
Standard italiani per la cura del diabete mellito
2018 (free full text).

Roglic G, Norris SL.
Medicines for treatment intensification in type 2 diabetes and type of insulin in type 1 and type 2 diabetes in low-resource settings: synopsis of the World Health Organization guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in nonpregnant adults with diabetes mellitus.
Ann Intern Med 2018, 169: 394-7 (free full text).

Flanagan D, Dhatariya K, Kilvert A, on behalf of the Joint British Diabetes Societies (JBDS) for Inpatient Care group* and Guidelines writing group*.
Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.
Diabet Med 2018, DOI: 10.1111/dme.13677.

Frankel AH, Kazempour-Ardebili S, Bedi R, et al.
Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal Association.
Diabet Med 2018, 35: 1018–26.

Roberts AW, Penfold S, on behalf of the Joint British Diabetes Societies (JBDS) for Inpatient Care.
Glycaemic management during the inpatient enteral feeding of people with stroke and diabetes.
Diabet Med 2018, 35: 1027–36.

Roberts A, James J, Dhatariya K, on behalf of the Joint British Diabetes Societies (JBDS) for Inpatient Care.
Management of hyperglycaemia and steroid  (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.
Diabet Med 2018, 35: 1011–7.

Dyson PA, et al.
Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes.
Diabetic Medicine 2018, doi: 10.1111/dme.13603.

Villani M, de Courten B, Zoungas S.
Emergency treatment of hypoglycaemia: a guideline and evidence review.
Diabetic Medicine 2017, 34: 1205-11 (free full text).

Qaseem A, Barry MJ, Humphrey LH, et al for the Clinical Guidelines Committee of the American College of Physicians.
Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the American College of Physicians.
Ann Intern Med 2017, 166: 279-90 (free full text).

Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H.
Diabetes technology—continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2016, DOI: 10.1210/jc.2016-2534.

Ali S, Davies MJ, Brady EM, Gray LJ, Khunti K, Beshyah SA, Hanif W.
Guidelines for managing diabetes in Ramadan.
Diabet Med 2016, 33: 1315-29.

Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL.
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Diabetologia 2015, 58: 862–70 (free full text).

Chiang JL, et al.
Type 1 diabetes through the life span: a position statement of the American Diabetes Association.
Diabetes Care 2014, 37: 2034–54 (free full text)

International Diabetes Federation Guideline Development Group
Global guideline for type 2 diabetes
Diabetes Res Clinical Pract 2014, 104: 1–52.

Aiello A, et al.
Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE).
Nutrition Metab Cardiovasc Dis 2014, doi:10.1016/j.numecd.2013.12.007.

Evert AB, et al.
Nutrition therapy recommendations for the management of adults with diabetes.
Diabetes Care 2013, 36: 3821-42 (free full text).

Wukich DK, et al.
Inpatient management of diabetic foot disorders: a clinical guide.
Diabetes Care 2013, 36: 2862–71

Blumer I, Hadar E, Hadden DR, et al.
Diabetes and pregnancy: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2013, 98: 4227–49.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Can J Diabetes 2013, 37 (suppl 1): S1-S212.

Riethof M, Flavin PL, Lindvall B, Michels R, O’Connor P, Redmon B, Retzer K, Roberts J, Smith S, Sperl-Hillen J. Institute for Clinical Systems Improvement.
Diagnosis and Management of Type 2 Diabetes Mellitus in Adults.
http://bit.ly/Diabetes0412. Updated April 2012.

Dhatariya K, et al.
Diabetes UK Position Statements and Care Recommendations. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes.
Diabet Med 2012, 29: 420–33.

National Institute for Clinical Excellence
Hyperglycaemia in acute coronary syndromes. Management of hyperglycaemia in people with acute coronary syndromes.
Ottobre 2011.

Joint British Diabetes Societies Inpatient Care Group.
The Management of Diabetic Ketoacidosis in Adults.
Marzo 2010.

Conferenza nazionale 2010 di consenso per raccomandazioni e implementazione delle nuove linee guida per lo screening e la diagnosi del diabete gestazionale: leggi

Philip E Cryer, Lloyd Axelrod, Ashley B Grossman, Simon R Heller, Victor M Montori, Elizabeth R Seaquist, F John Service
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
J Clin Endocrinol Metab 2009, 94: 709–28.